Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019

Hepatitis B virus (HBV) and hepatitis C virus (HCV) contribute to significant healthcare burden globally. We aim to provide an updated and comprehensive analysis of global trends in the incidence and mortality of HBV and HCV related acute infections, cirrhosis and hepatocellular carcinoma (HCC). Est...

Full description

Saved in:
Bibliographic Details
Published in:Journal of viral hepatitis 2022-05, Vol.29 (5), p.352-365
Main Authors: Veracruz, Nicolette, Gish, Robert G., Cheung, Ramsey, Chitnis, Amit S., Wong, Robert J.
Format: Article
Language:English
Subjects:
Carcinoma, Hepatocellular
Cirrhosis
Disease
Epidemiology
Hepacivirus
Hepatitis B
Hepatitis B - complications
Hepatitis B - epidemiology
Hepatitis B virus
Hepatitis C
Hepatitis C - complications
Hepatitis C - epidemiology
Hepatocellular carcinoma
Humans
Incidence
Infections
Liver cancer
Liver cirrhosis
Liver Cirrhosis - complications
Liver Cirrhosis - epidemiology
liver disease
Liver Neoplasms - etiology
Mortality
Risk Factors
Trends
vaccination
viral hepatitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatitis B virus (HBV) and hepatitis C virus (HCV) contribute to significant healthcare burden globally. We aim to provide an updated and comprehensive analysis of global trends in the incidence and mortality of HBV and HCV related acute infections, cirrhosis and hepatocellular carcinoma (HCC). Estimates of annual cause‐specific disease incidence and mortality for HBV and HCV were analysed using the 2010–2019 Global Burden of Diseases, Injuries and Risk Factors Study database. Three distinct disease states were evaluated: acute infections, cirrhosis and HCC. Age‐standardized disease incidence and mortality were presented per 100,000 population and stratified by age, sex, year and 21 world regions. From 2010 to 2019, overall incidence of acute HBV declined by 19.3% (95% CI 4.1–32.0, p 
ISSN:1352-0504
1365-2893
DOI:10.1111/jvh.13663